Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: Results of GUSTO-I

This publication has 21 references indexed in Scilit:

• Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardial infarction
  American Heart Journal, 1996
• Activated Partial Thromboplastin Time and Outcome After Thrombolytic Therapy for Acute Myocardial Infarction
  Circulation, 1996
• Bedside coagulation monitoring in heparin-treated patients with active thromboembolic disease: A coronary care unit experience
  American Heart Journal, 1994
• Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA)
  Journal of the American College of Cardiology, 1992
• Heparin-induced prolongation of partial thromboplastin time after thrombolysis: Relation to coronary artery patency
  Journal of the American College of Cardiology, 1992
• Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial Infarction
  Annals of Internal Medicine, 1991
• Adjuncts to Thrombolysis for Myocardial Reperfusion
  Annals of Internal Medicine, 1991
• Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction
  New England Journal of Medicine, 1989
• Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction
  The American Journal of Cardiology, 1987
• Control of Heparin Therapy With Activated Partial Thromboplastin Times
  JAMA, 1967